Achieve Life Sciences, Inc.
ACHV
$5.10
$0.255.16%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -51.99M | -54.65M | -52.35M | -50.42M | -46.16M |
| Total Depreciation and Amortization | 223.00K | 228.00K | 229.00K | 232.00K | 234.00K |
| Total Amortization of Deferred Charges | 50.00K | 52.00K | 55.00K | 51.00K | 37.00K |
| Total Other Non-Cash Items | 5.88M | 9.17M | 9.45M | 8.90M | 7.90M |
| Change in Net Operating Assets | 531.00K | -4.27M | 1.94M | 1.51M | 2.42M |
| Cash from Operations | -45.31M | -49.47M | -40.68M | -39.72M | -35.57M |
| Capital Expenditure | -3.00K | -3.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 4.00K | 4.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.03M | 6.11M | 17.12M | 43.04M | -10.23M |
| Cash from Investing | 9.03M | 6.11M | 17.12M | 43.04M | -10.23M |
| Total Debt Issued | 5.00M | 5.00M | 0.00 | 9.81M | 9.81M |
| Total Debt Repaid | -- | -- | 0.00 | -18.11M | -18.11M |
| Issuance of Common Stock | 46.55M | 46.53M | 45.95M | 42.09M | 865.00K |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -153.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 51.55M | 51.53M | 45.95M | 33.79M | -7.58M |
| Foreign Exchange rate Adjustments | 4.00K | 3.00K | -2.00K | 0.00 | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.28M | 8.18M | 22.39M | 37.12M | -53.38M |